Search alternatives:
ht decrease » _ decrease (Expand Search), step decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 ht » 5 h (Expand Search)
ht decrease » _ decrease (Expand Search), step decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 ht » 5 h (Expand Search)
-
12241
-
12242
-
12243
-
12244
Solid State and Aqueous Solution Characterization of Rectangular Tetranuclear V<sup>IV/V</sup>-<i>p</i>-Semiquinonate/Hydroquinonate Complexes Exhibiting a Proton Induced Electron...
Published 2008“…Reaction of the non-innocent dinucleating ligand 2,5-bis[N,N-bis(carboxymethyl) aminomethyl]hydroquinone (H<sub>6</sub>bicah) with VO<sup>2+</sup> and VO<sub>4</sub><sup>3−</sup> salts in water in the pH range 2 to 4.5 provides a series of novel tetranuclear V<sup>IV</sup> and/or V<sup>V</sup> macrocycles with the main core consisting of the anions [V<sup>V</sup><sub>4</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicah)<sub>2</sub>]<sup>4−</sup> isolated at pH = 2.5 and [V<sup>IV</sup><sub>2</sub>V<sup>V</sup><sub>2</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicas)(μ-bicah)]<sup>5−</sup> and [V<sup>IV</sup><sub>4</sub>O<sub>4</sub>(μ-O)<sub>2</sub>(μ-bicas)<sub>2</sub>]<sup>6−</sup> isolated at pH = 4.5 (bicas<sup>•5−</sup> = 2,5-bis[N,N-bis(carboxymethyl) aminomethyl]-<i>p</i>-semiquinonate), whereas at pH = 2 the dinuclear [(V<sup>IV</sup>O)<sub>2</sub>(OH<sub>2</sub>)<sub>2</sub>(μ-bicah)]<sup>2−</sup> was obtained. …”
-
12245
Representative fluorescent records of IntegriSense 680<sup>®</sup> dye-labeled αvβ3 integrin in control and cetrorelix-treated non-pregnant rats.
Published 2024“…Cetrorelix treatment reduced αvβ3 integrin expression, which caused a significant decrease in intensity (bottom image row). …”
-
12246
Combinatorial treatment increases IKAP levels in human cells generated from Familial Dysautonomia patients
Published 2019“…<div><p>Familial Dysautonomia (FD) is an autosomal recessive congenital neuropathy that results from a point mutation at the 5’ splice site of intron 20 in the <i>IKBKAP</i> gene. …”
-
12247
-
12248
-
12249
-
12250
Image_5_COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective.TIF
Published 2021“…The activity of clinical trials was decreased as the number of COVID-19 patients was increased, and a statistically negative correlation was observed between the prevalence of COVID-19 and the percentage decrease in the number of clinical trials stared or reported results. …”
-
12251
Excel data file with all collected data.
Published 2025“…During the five-day treatment period and at a follow-up visit after 30 days we closely monitored adverse events and collected self-rated side effect data. …”
-
12252
-
12253
-
12254
-
12255
Moldable Strong Cation Exchange Polymer and Microchannel Fabrication
Published 2020“…We characterize a high-capacity cation exchange membrane (CEM) synthesized from an aqueous poly(vinyl alcohol) (PVA) solution and varying amounts of a water-soluble ionic monomer, sodium styrenesulfonate. …”
-
12256
Moldable Strong Cation Exchange Polymer and Microchannel Fabrication
Published 2020“…We characterize a high-capacity cation exchange membrane (CEM) synthesized from an aqueous poly(vinyl alcohol) (PVA) solution and varying amounts of a water-soluble ionic monomer, sodium styrenesulfonate. …”
-
12257
-
12258
-
12259
Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening
Published 2019“…However, current screening methods for rexinoids are slow and require special apparatus or facilities. Here, we created 7-hydroxy-2-oxo-6-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-2<i>H</i>-chromene-3-carboxylic acid (<b>10</b>, CU-6PMN) as a new fluorescent RXR agonist and developed a screening system of rexinoids using <b>10</b>. …”
-
12260